Physician profile
James D Flaherty
NPI 1598793903
$37,946.39
in general payments reported to CMS, 2019-2025
23 companies · $4,765 in 2025
The $4,765 reported for 2025 was more than what 82% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,539 · 2020: $690 · 2021: $505 · 2022: $1,102 · 2023: $11K · 2024: $18K · 2025: $4,765.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $23K · Food and Beverage: $5,816 · Travel and Lodging: $4,882.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $23,412.50 |
| Food and Beverage | $5,816.35 |
| Travel and Lodging | $4,881.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $30,397.75 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Pascal |
| Abbott Laboratories | $3,439.36 | 2019-2025 | Mitraclip, Optis, Navitor |
| Boston Scientific Corporation | $1,295.58 | 2019-2025 | Stingray, Watchman Flx, Watchman |
| Abiomed | $338.10 | 2019-2025 | Impella |
| Ancora Heart, INC. | $336.77 | 2022-2023 | Accucinch |
| W. L. Gore & Associates, INC. | $265.44 | 2020-2023 | Gore Cardioform Septal Occluder |
| Medtronic, INC. | $245.56 | 2023-2024 | Corevalve Evolut R, Apollotm |
| Shockwave Medical, INC | $219.53 | 2020-2022 | |
| Cardiovascular Systems INC. | $179.33 | 2020 | |
| Cardiva Medical, INC. | $177.62 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Recor Medical INC | $171.62 | 2025 | Paradise Ultrasound Renal Denervation System |
| Philips North America LLC | $156.98 | 2025 | Coronary Other, Eagle Eye |
| Zoll Circulation INC | $154.00 | 2024 | Downstream Cartridge, Catheter, Therox Ds2 Console |
| Biosense Webster, INC. | $140.40 | 2024 | Nuvision Ice Catheter |
| Penumbra, INC. | $115.48 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $84.61 | 2022 | |
| Pfizer INC. | $73.00 | 2024 | |
| Stryker Corporation | $46.69 | 2025 | Flowtriever |
| Cordis US Corp. | $30.79 | 2024-2025 | Mynx Control Venous, Mynx Control |
| Inari Medical, INC. | $22.48 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novo Nordisk INC | $22.06 | 2024 | Wegovy |
| Chiesi USA, INC. | $18.61 | 2019 | |
| Terumo Medical Corporation | $14.63 | 2024 | Angio-Seal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Flaherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.